Jose Antonio Lopez-Martin

机构：PharmaMar (Spain) · ORCID：0000-0001-7530-3207

发表论文 238 篇 · 总被引 11537 次 · h-index 38

代表论文

SARS-CoV-2 variants evolve convergent strategies to remodel the host response (2023 · Cell · 被引 118)
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single‐arm, phase 2 trial (2024 · Cancer · 被引 27)
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry (2023 · ESMO Open · 被引 25)
Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis (2023 · The Oncologist · 被引 25)
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19 (2024 · Clinical Infectious Diseases · 被引 17)
3D bioprinted functional skeletal muscle models have potential applications for studies of muscle wasting in cancer cachexia (2023 · Biomaterials Advances · 被引 16)